Kowa Co Ltd, a Japanese trading and pharmaceuticals company said that the anti-parasite drug, Ivermectin, may have an “antiviral effect” against Omicron.
ivermectin also had effects on other variants of COVID-19 in non-clinical research.
Will this be a new treatment option for COVID-19?
There are ongoing clinical trails, but promoting Ivermectin as treatment has led to some controversy.
Ivermectin has not been approved for treatment of COVID-19 in Japan. The United States Food & Drug Administration, the World Health Organization, the EU drug regulator and Merck, which makes the drug, have all cautioned its use.
These companies have warned against it’s use for lack of scientific evidence.
There are numerous reports of patients who had required medical attention, including hospitalization, after self-medicating with it.
University of Oxford is currently investigating the use of Ivermectin to treat COVID-19 in a trail run.
“Many potential COVID-19 treatments that showed promise in test tubes…[but] ultimately failed to show benefit for COVID-19 patients once studied in clinical trials.”
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].